{"id":"https://openalex.org/W4397046226","doi":"https://doi.org/10.1681/asn.20223311s1896a","title":"Treatment of Cisplatin-Induced AKI With Renal Selective Nanotherapy","display_name":"Treatment of Cisplatin-Induced AKI With Renal Selective Nanotherapy","publication_year":2022,"publication_date":"2022-11-01","ids":{"openalex":"https://openalex.org/W4397046226","doi":"https://doi.org/10.1681/asn.20223311s1896a"},"language":"en","primary_location":{"id":"doi:10.1681/asn.20223311s1896a","doi":"https://doi.org/10.1681/asn.20223311s1896a","is_oa":false,"landing_page_url":"https://doi.org/10.1681/asn.20223311s1896a","pdf_url":null,"source":{"id":"https://openalex.org/S115693375","display_name":"Journal of the American Society of Nephrology","issn_l":"1046-6673","issn":["1046-6673","1533-3450"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315620","host_organization_name":"American Society of Nephrology","host_organization_lineage":["https://openalex.org/P4310315620"],"host_organization_lineage_names":["American Society of Nephrology"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of the American Society of Nephrology","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5000305243","display_name":"Chintan H. Kapadia","orcid":"https://orcid.org/0000-0001-8068-0250","observed_orcids":["https://orcid.org/0000-0001-8068-0250"]},"institutions":[{"id":"https://openalex.org/I4210142924","display_name":"Chrysalis BioTherapeutics (United States)","ror":"https://ror.org/051zy3f83","country_code":"US","type":"company","lineage":["https://openalex.org/I4210142924"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Chintan H. Kapadia","raw_affiliation_strings":["Goldilocks Therapeutics Inc., Wilmington, DE"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Goldilocks Therapeutics Inc., Wilmington, DE","institution_ids":["https://openalex.org/I4210142924"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5037355958","display_name":"Daniel A. Heller","orcid":"https://orcid.org/0000-0002-6866-0000","observed_orcids":["https://orcid.org/0000-0002-6866-0000"]},"institutions":[{"id":"https://openalex.org/I1334819555","display_name":"Memorial Sloan Kettering Cancer Center","ror":"https://ror.org/02yrq0923","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1334819555"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Daniel A. Heller","raw_affiliation_strings":["Memorial Sloan Kettering Cancer Center, New York, NY"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Memorial Sloan Kettering Cancer Center, New York, NY","institution_ids":["https://openalex.org/I1334819555"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5024731714","display_name":"Magdalini Panagiotakopoulou","orcid":"https://orcid.org/0000-0001-6293-4579","observed_orcids":["https://orcid.org/0000-0001-6293-4579"]},"institutions":[{"id":"https://openalex.org/I1334819555","display_name":"Memorial Sloan Kettering Cancer Center","ror":"https://ror.org/02yrq0923","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1334819555"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Magdalini Panagiotakopoulou","raw_affiliation_strings":["Memorial Sloan Kettering Cancer Center, New York, NY"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Memorial Sloan Kettering Cancer Center, New York, NY","institution_ids":["https://openalex.org/I1334819555"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5046186654","display_name":"Edgar A. Jaimes","orcid":"https://orcid.org/0000-0002-5756-5120","observed_orcids":["https://orcid.org/0000-0002-5756-5120"]},"institutions":[{"id":"https://openalex.org/I1334819555","display_name":"Memorial Sloan Kettering Cancer Center","ror":"https://ror.org/02yrq0923","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1334819555"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Edgar A. Jaimes","raw_affiliation_strings":["Memorial Sloan Kettering Cancer Center, New York, NY"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Memorial Sloan Kettering Cancer Center, New York, NY","institution_ids":["https://openalex.org/I1334819555"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"33","issue":"11S","first_page":"896","last_page":"896"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T12429","display_name":"Chemotherapy-induced organ toxicity mitigation","score":0.9398999810218811,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T12429","display_name":"Chemotherapy-induced organ toxicity mitigation","score":0.9398999810218811,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10684","display_name":"Acute Kidney Injury Research","score":0.05510000139474869,"subfield":{"id":"https://openalex.org/subfields/2727","display_name":"Nephrology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10063","display_name":"Nanoparticle-Based Drug Delivery","score":0.0031999999191612005,"subfield":{"id":"https://openalex.org/subfields/2502","display_name":"Biomaterials"},"field":{"id":"https://openalex.org/fields/25","display_name":"Materials Science"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/cisplatin-induced-acute-kidney-injury","display_name":"cisplatin-induced acute kidney injury","score":0.9800000190734863},{"id":"https://openalex.org/keywords/renal-proximal-tubular-epithelial-cells","display_name":"renal proximal tubular epithelial cells","score":0.7390000224113464},{"id":"https://openalex.org/keywords/nanoparticle-drug-delivery","display_name":"nanoparticle drug delivery","score":0.7839999794960022},{"id":"https://openalex.org/keywords/edaravone","display_name":"edaravone","score":0.8640000224113464},{"id":"https://openalex.org/keywords/free-radical-scavengers","display_name":"radical scavengers","score":0.8370000123977661},{"id":"https://openalex.org/keywords/biodegradable-nanoparticles","display_name":"biodegradable nanoparticles","score":0.8870000243186951},{"id":"https://openalex.org/keywords/pig-model","display_name":"porcine model","score":0.6209999918937683},{"id":"https://openalex.org/keywords/pharmacokinetics","display_name":"pharmacokinetics","score":0.9340000152587891},{"id":"https://openalex.org/keywords/tissue-distribution","display_name":"tissue distribution","score":0.8240000009536743},{"id":"https://openalex.org/keywords/nephrotoxicity","display_name":"nephrotoxicity","score":0.8790000081062317}],"concepts":[{"id":"https://openalex.org/C2778239845","wikidata":"https://www.wikidata.org/wiki/Q412415","display_name":"Cisplatin","level":3,"score":0.7318034172058105},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5903710126876831},{"id":"https://openalex.org/C2780472472","wikidata":"https://www.wikidata.org/wiki/Q424337","display_name":"Acute kidney injury","level":2,"score":0.49483245611190796},{"id":"https://openalex.org/C126894567","wikidata":"https://www.wikidata.org/wiki/Q105650","display_name":"Urology","level":1,"score":0.37017494440078735},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.34035587310791016},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.15092304348945618}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1681/asn.20223311s1896a","doi":"https://doi.org/10.1681/asn.20223311s1896a","is_oa":false,"landing_page_url":"https://doi.org/10.1681/asn.20223311s1896a","pdf_url":null,"source":{"id":"https://openalex.org/S115693375","display_name":"Journal of the American Society of Nephrology","issn_l":"1046-6673","issn":["1046-6673","1533-3450"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315620","host_organization_name":"American Society of Nephrology","host_organization_lineage":["https://openalex.org/P4310315620"],"host_organization_lineage_names":["American Society of Nephrology"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of the American Society of Nephrology","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":1.0,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W3002123044","https://openalex.org/W3083302105","https://openalex.org/W4206005685","https://openalex.org/W4415319986","https://openalex.org/W7221736744","https://openalex.org/W7167664845","https://openalex.org/W4396998813","https://openalex.org/W3173429476","https://openalex.org/W4225001741","https://openalex.org/W7202352278"],"abstract_inverted_index":{"Background:":[0],"Acute":[1],"kidney":[2,107],"injury":[3,108],"(AKI)":[4],"occurs":[5],"in":[6,31,105,109,127,165,188],"up":[7,26,37,50],"to":[8,27,38,51],"30%":[9],"of":[10,21,29,40,59,116,132,159,169,174,184,193],"cancer":[11],"patients":[12,30,42],"treated":[13],"with":[14,47,89],"cisplatin,":[15],"and":[16,36,56,141,157,181],"accounts":[17],"for":[18],"approximately":[19],"1%":[20],"total":[22],"hospital":[23],"admissions.":[24],"Further,":[25],"25%":[28,39],"intensive":[32],"care":[33],"develop":[34],"AKI":[35,125],"these":[41,197],"require":[43],"renal":[44,81],"replacement":[45],"therapy":[46],"mortality":[48],"rates":[49],"60%.":[52],"Despite":[53],"the":[54,112,206],"prevalence":[55],"associated":[57],"morbidities":[58],"AKI,":[60],"there":[61],"are":[62,153],"no":[63],"therapeutics":[64],"that":[65],"specifically":[66],"treat":[67],"this":[68,175],"disease.":[69],"Methods:":[70],"We":[71],"synthesized":[72],"proprietary":[73],"nanoparticles":[74,100],"from":[75,146,196],"biodegradable":[76],"materials":[77],"which":[78],"preferentially":[79],"target":[80],"proximal":[82],"tubular":[83],"epithelial":[84],"cells.":[85],"Nanoparticles":[86],"were":[87,143],"loaded":[88],"free":[90],"radical":[91],"scavenger":[92],"molecule,":[93],"Edaravone.":[94],"In":[95],"previously":[96],"published":[97],"studies,":[98],"our":[99,117,160,166],"exhibited":[101],"significant":[102],"therapeutic":[103],"efficacy":[104,158,182],"cisplatin-induced":[106],"mice.":[110],"For":[111],"successful":[113],"clinical":[114],"translation":[115],"lead":[118,161,186],"therapeutics,":[119,162],"we":[120,152],"have":[121],"developed":[122],"cisplatin":[123,135],"induced":[124],"model":[126,168,192],"pigs.":[128],"Results:":[129],"After":[130],"administration":[131],"5":[133],"mg/kg":[134],"intravenously,":[136],"blood":[137],"urea":[138],"nitrogen":[139],"(BUN)":[140],"creatinine":[142],"significantly":[144],"elevated":[145],"baseline":[147],"post":[148],"72":[149],"hours.":[150],"Currently,":[151],"evaluating,":[154],"biodistribution,":[155],"pharmacokinetics":[156],"Edaravone":[163],"nanoparticles,":[164],"pig":[167],"CI-AKI.":[170,194],"Conclusions:":[171],"The":[172],"results":[173],"work":[176],"will":[177,199],"provide":[178,200],"pharmacokinetic,":[179],"safety,":[180],"data":[183],"a":[185,189],"candidate":[187],"large":[190],"animal":[191],"Results":[195],"studies":[198],"essential":[201],"final":[202],"validation":[203],"before":[204],"initiating":[205],"remaining":[207],"CMC/IND-enabling":[208],"studies.":[209],"Funding:":[210],"NIDDK":[211],"Support":[212]},"counts_by_year":[],"updated_date":"2026-07-14T23:27:15.235271","created_date":"2024-05-19T00:00:00"}